SXTP Stock Analysis: Buy, Sell, or Hold?
SXTP - 60 Degrees Pharmaceuticals, Inc. Common Stock
$4.15
-0.69 (-14.26%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When SXTP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SXTP is 27.3% above fair value ($3.26). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SXTP is 27.3% above fair value ($3.26). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SXTP is currently trading at $4.15, which is considered extended relative to its 30-day fair value range of $-0.18 to $3.26.
Technical Outlook: Technically, SXTP is showing sideways momentum. Immediate support is located at $0.47, while resistance sits at $8.62. Short-term momentum is weak, with the stock down 14.3% recently.
Market Sentiment: SXTP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.60 (+263.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SXTP is showing sideways momentum. Immediate support is located at $0.47, while resistance sits at $8.62. Short-term momentum is weak, with the stock down 14.3% recently.
Market Sentiment: SXTP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.60 (+263.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$-0.18 -
$3.26
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
Protect Your Profits
Holding SXTP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+27.3% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-14.3%)
- BULLISH: Trading 263.6% below Wall St target ($17.60)
- WARNING: Recommendation downgraded due to 27.3% overvaluation
Fair Price Analysis
30-Day Fair Range
$-0.18 -
$3.26
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.47
Resistance Level
$8.62
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-0.61
Wall Street Target
$17.60
(+263.6%)
Revenue Growth (YoY)
256.9%
Last updated: January 31, 2026 5:46 AM ET
Data refreshes hourly during market hours. Next update: 6:46 AM
Data refreshes hourly during market hours. Next update: 6:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SXTP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced SXTP Option Strategies
Professional options setups generated by AI based on today's SXTP price and gamma walls.
